2020
DOI: 10.1038/s41434-020-0148-6
|View full text |Cite
|
Sign up to set email alerts
|

Gene therapy for cardiovascular diseases in China: basic research

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 94 publications
0
9
0
Order By: Relevance
“…Two microRNAs from the opposite side of the pre-microRNA name−3p or−5p (55). In recent years, studies have showed that microRNAs play essential roles in the pathogenesis of muscle atrophy induced by heart failure (56). The expression of miR-23a in muscle atrophy was less than controls, and resistance exercise increased the levels of miR-23a and miR-27a.…”
Section: Roles Of Microrna In Muscle Atrophy Induced By Heart Failurementioning
confidence: 99%
“…Two microRNAs from the opposite side of the pre-microRNA name−3p or−5p (55). In recent years, studies have showed that microRNAs play essential roles in the pathogenesis of muscle atrophy induced by heart failure (56). The expression of miR-23a in muscle atrophy was less than controls, and resistance exercise increased the levels of miR-23a and miR-27a.…”
Section: Roles Of Microrna In Muscle Atrophy Induced By Heart Failurementioning
confidence: 99%
“…With the acceleration of population aging, prevalence of MI patients will continue to increase [3] . Although the increasingly developed medical technology and reperfusion therapy post-MI can save patients' lives and improve clinical symptoms [4] , it is still unable to fundamentally reverse or terminate the further development of heart failure post-MI. Therefore, it is urgent to develop novel strategies to attenuate post-MI remodeling and heart failure.…”
Section: Introductionmentioning
confidence: 99%
“…Non‐viral gene complexes are administered by intravenous injection, [ 6 ] intramuscular injection, [ 7 ] intradermal injection, [ 8 ] mucosal delivery, [ 9 ] and transdermal delivery. [ 10 ] Adopting a non‐intravenous administration approach could ensure that gene complexes effectively escape nuclease degradation and phagocytosis by the reticuloendothelial system.…”
Section: Introductionmentioning
confidence: 99%